Oxygen Biotherapeutics, Inc. Issues Letter to Shareholders

Published: Aug 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (“OBI”) (NASDAQ: OXBT) a developer of oxygen-carrying therapeutics, today announced the Company has issued a Letter to Shareholders.

Help employers find you! Check out all the jobs and post your resume.

Back to news